Carl Dieffenbach, Ph.D., Director of the Division of AIDS, NIAID

10-02-2024Cross-posted from: NIAID Now Blog This blog is the third in a series about the future of NIAID's HIV clinical research enterprise. For more information, please…

10-05-2017Cross-posted from National Institute of Allergy and Infectious Diseases, NIH As the National Institutes of Health works to refine its HIV clinical trial…

09-21-2017Cross-posted from NIAID.Take a moment to imagine the future of the HIV pandemic, and how we as the research community can make that future better. Do you…

02-14-2017Antiretroviral therapy (ART) has transformed HIV infection from an almost-always fatal disease to what is now a manageable, chronic health condition. Today, a…

11-30-2015When the first cases of what would become known as AIDS were reported in 1981, scientists and physicians did not know the cause and had no therapies to treat…

02-24-2015As the 2015 Conference on Retroviruses and Opportunistic Infections (CROI) got underway in Seattle yesterday, February 23, we spoke with Dr. Carl Dieffenbach,…

03-08-2013Dr. Anthony Fauci Dr. Carl DieffenbachOn Monday, March 4, 2013, at the Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta, Dr. Deborah…

06-10-2010Over the next several weeks, the National Institute of Allergy and Infectious Diseases (NIAID) will post a series of entries here on HIV.gov related to…

12-04-2009Earlier this week, we commemorated World AIDS Day, a time to examine the progress that the global community has made against the HIV/AIDS global pandemic…